| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC23856 | CEP-7055 | CEP-7055 is a potent, orally active, pan inhibitor of VEGFR, CEP-7055 is the dimethylglycine ester prodrug of CEP-5214, which inhibits human VEGFR2/KDR kinase, VEGFR1/FLT-1 kinase, and VEGFR3/FLT-4 kinase with IC50 of 18 nM, 12 nM, and 17 nM. |
|
| DC7347 | Cephalosporin C Na salt Featured | Cephalosporin C Na salt is used to study the effect of transpeptidase expression, binding, and inhibition on bacterial cell wall mucopeptide synthesis. |
.png)
|
| DC7346 | Cephalosporin C zinc salt Featured | Cephalosporin C zinc salt is used to study the effect of transpeptidase expression, binding, and inhibition on bacterial cell wall mucopeptide synthesis. |
|
| DC9649 | Cephalotaxlen Featured | Cephalotaxine is an antiviral as well as antitumor agent. |
|
| DC10226 | Cefradine | Cephradine is a semi-synthetic cephalosporin antibiotic. |
|
| DC9765 | CERC-501(LY-2456302,Aticaprant) Featured | CERC-501(LY-2456302) is a potent, selective antagonist of the kappa opioid receptor (KOR) (Ki = 0.81 nM vs. 24.0 nM and 155 nM for the μ-opioid receptor (MOR) and δ-opioid receptor (DOR), respectively. |
|
| DC7814 | Cerdulatinib(PRT-062070; PRT2070) Featured | Cerdulatinib(PRT-062070; PRT2070) is an novel oral dual Syk/JAK inhibitor. |
|
| DC9154 | Cetirizine 2HCl | Cetirizine 2Hcl, a second-generation antihistamine, is a major metabolite of hydroxyzine, and a racemic selective H1 receptor inverse agonist used in the treatment of allergies, hay fever, angioedema, and urticaria. |
|
| DC9500 | Cevimeline (hydrochloride hemihydrate) Featured | Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. |
|
| DC7899 | Cevipabulin(TTI 237) | Cevipabulin, also known as TTI-237, an antimicrotubule agent, is a small synthetic molecule of triazolopyrimidine derivative with potential antitumor activity. |
|
| DC10440 | Namodenoson (CF-102) Featured | CF-102(2-Cl-IB-MECA) is a selective A3 adenosine receptor agonist (Ki = 0.33 nM). Displays 2500- and 1400-fold selectivity over A1 and A2A receptors respectively. target: A3 adenosine receptor agonist; |
|
| DC22052 | CFI02 | CFI02 (CFI-02) is a specific inhibitor of human cytomegalovirus (HCMV) glycoprotein B-mediated fusion with IC50 of 40 nM against laboratory adapted HCMV strain AD169. |
|
| DC10069 | CFI-400437 Featured | CFI-400437 is potent against PLK4 (IC50 = 0.6 nM) and selective against other members of the PLK family (>10 uM). |
|
| DC23338 | CFI-401980 | CFI-401980 is a potent, selective, novel class TTK (Tyrosine Threonine Kinase) inhibitor with Ki of 0.8 nM, HCT116 GI50 of 13 nM. |
|
| DC9340 | CFM-2 | CFM-2 is a selective non-competitive AMPAR antagonist. |
|
| DC11133 | CFM-4.16 | CFM-4.16 is a CARP-1 functional mimetic (CFM) compound bind with CARP-1, stimulates CARP-1 expression and apoptosis. |
|
| DC22809 | c-FMS-IN-8 Featured | c-FMS-IN-8 is a potent, selective c-FMS kinase inhibitor with IC50 of 0.8 nM, shows activity in collagen-induced model of arthritis in mice.. |
|
| DC7039 | CFTR Inhibitor II Featured | CFTR Inhibitor II is a cell-permeable glycinyl hydrazone compound that acts as a potent, selective and reversible open-channel blocker of CFTR with intermediate speed (< 1 min; 95% inhibition at 50 µM; Ki = 4.3 µM in CFTR-expressing FRT cells. |
|
| DC12580 | CG-806 Featured | CG-806 (CG806, CG'806) is a novel potent, pan-FLT3/BTK multi-kinase inhibitor with impressive inhibition of leukemic cell proliferation with IC50 at sub-nanomolar or low nanomolar levels. |
|
| DC7380 | CGI-1746 Featured | CGI1746 is a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation. |
|
| DC7101 | CGK733 Featured | CGK 733 is a potent and selective inhibitor of ATM/ATR with IC50 of ~200 nM. |
|
| DC10843 | CGP 52432 Featured | CGP 52432 is a potent, selective GABAB receptor antagonist (IC50 = 85 nM). |
|
| DC7381 | CGP-57380 Featured | CGP 57380 is a cell-permeable pyrazolo-pyrimidine compound that acts as a selective inhibitor of Mnk1 (IC50 = 2.2 μM) with no inhibitory activity against p38, JNK1, ERK1/2, PKC, or Src-like kinases. |
|
| DC10722 | CGP-71683A Featured | CGP 71683A is a potent and highly selective non-peptide antagonist of the NPY Y(5) receptor in the study of obesity. |
|
| DC9849 | CGP37849 | CGP37849 is a potent, selective and competitive NMDA receptor antagonist (Ki = 35 nM). Anticonvulsive following oral administration in vivo. |
|
| DC23919 | CGP-42112 Featured | CGP-42112 (CGP42112A) is a highly potent, selective Angiotensin-II subtype 2 receptor(AT2 receptor) agonist with Ki of 0.24 nM. |
|
| DC23830 | CGP-53353 | CGP-53353 (DAPH-7) is a selective inhibitor of PKCβII with IC50 of 0.41 uM, shows weak activity on PKCβI with IC50 of 3.8 uM. |
|
| DC20887 | CGP-74514A hydrochloride | CGP-74514A hydrochloride is a potent CDK1 inhibitor with IC50 of 25 nM. |
|
| DC8471 | CGS 21680 hydrochloride Featured | CGS 21680 hydrochloride is an A2A adenosine receptor agonist (Ki = 27 nM). |
|
| DC24112 | CGS 21680 | CGS 21680 is a specific adenosine A2A subtype receptor agonist with Ki of 27 nM. |
|
